– USA, MN – Cardiovascular Systems, Inc. (NASDAQ:CSII), today announced that, following a national search, it has named Scott R. Ward, 56, the company’s new Chairman and Chief Executive Officer, effective immediately. Ward has been serving as Chairman since November 2014 and Interim President and Chief Executive Officer since November 2015. He joined CSI’s board in 2013. Edward Brown, a member of CSI’s board since 2009, has been appointed as CSI’s Lead Independent Director.
“As a Director, Scott brings invaluable leadership and industry expertise to this organization,” said Leslie Trigg, Chair of CSI’s Governance/ Nominating Committee. “His knowledge of the company runs deep as does his commitment to its success. We look forward to supporting Scott in this new role.”
Said Ward, “I am pleased with the progress CSI has made to improve the quality of care for patients with coronary and peripheral artery disease. However, as the leader in atherectomy, we have much more to accomplish. I look forward to continuing to serve our patients, customers and shareholders by helping CSI achieve profitability and reach its full potential.”
About Cardiovascular Systems, Inc.
Cardiovascular Systems, Inc., based in St. Paul, Minn., is a medical device company focused on developing and commercializing innovative solutions for treating vascular and coronary disease. The company’s Orbital Atherectomy Systems treat calcified and fibrotic plaque in arterial vessels throughout the leg and heart in a few minutes of treatment time, and address many of the limitations associated with existing surgical, catheter and pharmacological treatment alternatives. The U.S. FDA granted 510(k) clearance for the use of the Diamondback Orbital Atherectomy System in peripheral arteries in August 2007. In October 2013, the company received FDA approval for the use of the Diamondback Orbital Atherectomy System in coronary arteries. The Stealth 360 Peripheral Orbital Atherectomy System received CE Mark in October 2014. To date, over 260,000 of CSI’s devices have been sold to leading institutions across the United States.
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.
